Growth hormone and diabetic retinopathy

Area of Science:

• Endocrinology
• Ophthalmology
• Metabolic Diseases

Background:

• Diabetic retinopathy is a major complication of diabetes mellitus.
• The role of growth hormone in diabetic retinopathy pathogenesis remains controversial.
• Previous studies show inconsistent findings regarding growth hormone levels and diabetic retinopathy.

Purpose of the Study:

• To investigate the relationship between serum growth hormone levels and the presence and severity of diabetic retinopathy.
• To compare growth hormone responses in diabetic patients with and without retinopathy to healthy controls.

Main Methods:

• Serum growth hormone was measured in 23 diabetic patients (16 with retinopathy, 7 without) and 8 healthy controls.
• Measurements were taken in the fasting state and 1 hour after levodopa administration.
• Fasting blood glucose levels were also assessed.

Main Results:

• Diabetic patients exhibited significantly higher mean growth hormone levels compared to controls.
• No correlation was found between mean growth hormone levels and the presence or absence of diabetic retinopathy.
• Diabetics with retinopathy showed significantly greater mean growth hormone responses after levodopa stimulation.
• Mean growth hormone levels did not correlate with fasting blood sugar.
• Patients with background retinopathy had higher mean growth hormone levels than those with proliferative retinopathy.

Conclusions:

• While elevated growth hormone is observed in diabetics, its direct correlation with the presence of retinopathy is not established.
• Growth hormone response to levodopa stimulation may be linked to retinopathy, particularly in background retinopathy.
• Further research is needed to clarify the complex role of growth hormone in diabetic retinopathy.